Abstract
The kidney is an active site of prostaglandin synthesis. These autacoids can influence renal haemodynamics, glomerular ultrafiltration coefficient, mesangial cell proliferation and matrix expansion. Due to these features, prostaglandins may contribute to virtually all the functional and structural alterations which characterize the different phases of diabetic nephropathy. Indeed, most of the experimental as well as clinical studies to date agree that renal hyperfiltration of early diabetes is partially dependent upon enhanced renal production of vasodilatory prostaglandins. By contrast, in long-term diabetes the reduced renal synthesis of prostaglandins and increased production of intrarenal thromboxane, be the latter derived from native glomerular cells or from infiltrating platelets or monocytes, would appear to contribute to the decline in glomerular filtration rate, glomerular basement membrane alterations and proteinuria.
Similar content being viewed by others
References
Van de Bosch H, Intracellular phospholipase A. Biochim Biophys Acta 604:191–246, 1980
Bell RL, Kennerly DA, Stanford N, Majerus PW, Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 76:3238–3241, 1979
Burch RH, Axelrod J, Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence for G protein regulation of phospholipase A2. Proc Natl Acad Sci USA 84:6374–6378, 1987
Ciabattoni G, Pugliese F, Studies of renal eicosanoids in vivo and in vitro. Adv Exp Med Bio 289:361–388, 1989
Pugliese F, Patrono C, Vasoactive hormones and autacoids regulating glomerular hemodynamics and mesangial cell proliferation. In: Gentilini P, Arias IM, Arroyo V, Schrier RW (eds) Liver disease and renal complications. Raven Press, New York, pp 300–307, 1990
Craven PA, Davidson CM, DeRubertis FR, Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667–674, 1990
Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI, High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F578, 1991
Craven PA, DeRubertis FR, Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: possible mediation by glucose. J Clin Invest 83:1667–1675, 1989
Pugliese F, Singh AK, Kasinath BS, Kreisberg JI, Lewis EJ, Glomerular epithelial cell polyanion neutralization is associated with enhanced prostanoid production. Kidney Int 32:57–61, 1987
Pugliese F, Menè P, Anania MC, Cinotti GA, Neutralization of the anionic sites of cultured mesangial cells by poly-L-lysine. Kidney Int 35:817–823, 1989
Moel DI, Safirstein RL, McEvoy RC, Hsueh W, Effect of aspirin on experimental diabetic nephropathy. J Lab Clin Med 110:300–307, 1987
Craven PA, DeRubertis FR, Role of local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptozotocin-induced diabetes. J Lab Clin Med 113:674–681, 1989
Gambardella S, Andreani D, Cancelli A, Di Mario U, Cardamone I, Stirati G, Cinotti GA, Pugliese F, Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1α and thromboxane B2 in newly diagnosed type I diabetic patients. Diabetes 37:1044–1048, 1988
Esmajetes E, Fernandez MR, Halperin I, Camps J, Gaya J, Arroyo V, Rivera F, Figuerola D, Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins. J Clin Endocrinol Metab 60:1231–1236, 1985
Craven PA, Patterson MC, DeRubertis FR, Role of enhanced arachidonate availability through the phospholipase A2 pathway in the mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37:429–435, 1988
Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C, Effects of sulindae and ibuprofen in patients with chronic glomerular disease. N Engl J Med 310:279–283, 1984
Hommel E, Mathiesen E, Arnold-Larsen S, Edsberg B, Olsen UB, Parving HH, Effects of indomethacin on kidney function in type I (insulin-dependent) diabetic patients with nephropathy. Diabetologia 30:78–81, 1987
Barnett AH, Leatherdale BA, Britton JR, Polak A, Bennett J, Toop M, Rowe D, Dallinger K, Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes, Lancet I:1322–1325, 1984
Donadio JV, Duane M, Ilsstrup MS, Holley KE, Romero JC, Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study. Mayo Clin Proc 63:3–15, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pugliese, F., Cinotti, G.A. & Menè, P. Prostaglandins and the kidney in diabetes. Acta Diabetol 29, 218–220 (1992). https://doi.org/10.1007/BF00573491
Issue Date:
DOI: https://doi.org/10.1007/BF00573491